{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:26Z","timestamp":1786120346915,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/inf.0b013e318292f425","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T10:24:07Z","timestamp":1364466247000},"page":"768-776","source":"Crossref","is-referenced-by-count":16,"title":["Seroprevalence and Placental Transmission of Maternal Antibodies Specific for Neisseria meningitidis Serogroups A, C, Y and W135 and Influence of Maternal Antibodies on the Immune Response to a Primary Course of MenACWY-CRM Vaccine in the United Kingdom"],"prefix":"10.1097","volume":"32","author":[{"given":"Geraldine","family":"Blanchard-Rohner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic F.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Kibwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Dull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20-20210202","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies.","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"R3-20-20210202","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1016\/j.vaccine.2007.06.020","article-title":"Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns.","volume":"25","author":"Leuridan","year":"2007","journal-title":"Vaccine"},{"key":"R4-20-20210202","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/10647440500068289","article-title":"Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants.","volume":"13","author":"Gonik","year":"2005","journal-title":"Infect Dis Obstet Gynecol"},{"key":"R5-20-20210202","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.4049\/jimmunol.175.4.2331","article-title":"A novel Fc gamma R-defined, IgG-containing organelle in placental endothelium.","volume":"175","author":"Takizawa","year":"2005","journal-title":"J Immunol"},{"key":"R6-20-20210202","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/S0264-410X(03)00334-7","article-title":"Placental transport of immunoglobulin G.","volume":"21","author":"Simister","year":"2003","journal-title":"Vaccine"},{"key":"R7-20-20210202","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1086\/599347","article-title":"Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis.","volume":"49","author":"de Voer","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R8-20-20210202","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1016\/S0264-410X(03)00342-6","article-title":"Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants.","volume":"21","author":"Siegrist","year":"2003","journal-title":"Vaccine"},{"key":"R9-20-20210202","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4138::AID-IMMU4138>3.0.CO;2-L","article-title":"Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice.","volume":"28","author":"Siegrist","year":"1998","journal-title":"Eur J Immunol"},{"key":"R10-20-20210202","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0264-410X(99)00539-3","article-title":"Diphtheria antitoxin response to DTP vaccines used in Swedish pertussis vaccine trials, persistence and projection for timing of booster.","volume":"18","author":"Tiru","year":"2000","journal-title":"Vaccine"},{"key":"R11-20-20210202","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.vaccine.2011.04.068","article-title":"Mother-infant vaccination with pneumococcal polysaccharide vaccine: persistence of maternal antibodies and responses of infants to vaccination.","volume":"29","author":"Holmlund","year":"2011","journal-title":"Vaccine"},{"key":"R12-20-20210202","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jama.2007.29-c","article-title":"Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.","volume":"299","author":"Snape","year":"2008","journal-title":"JAMA"},{"key":"R13-20-20210202","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JCM.32.6.1475-1482.1994","article-title":"Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay.","volume":"32","author":"Gheesling","year":"1994","journal-title":"J Clin Microbiol"},{"key":"R14-20-20210202","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/clinids\/4.1.159","article-title":"Epidemic meningococcal disease: synthesis of a hypothetical immunoepidemiologic model.","volume":"4","author":"Griffiss","year":"1982","journal-title":"Rev Infect Dis"},{"key":"R15-20-20210202","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2567.2008.02934.x","article-title":"Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.","volume":"127","author":"Kelly","year":"2009","journal-title":"Immunology"},{"key":"R16-20-20210202","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4049\/jimmunol.180.4.2165","article-title":"The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.","volume":"180","author":"Blanchard-Rohner","year":"2008","journal-title":"J Immunol"},{"key":"R17-20-20210202","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/blood-2006-01-009282","article-title":"CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen specific memory B cells.","volume":"180","author":"Kelly","year":"2006","journal-title":"Blood"},{"key":"R18-20-20210202","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/CDLI.5.4.479-485.1998","article-title":"A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses.","volume":"5","author":"Granoff","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"key":"R19-20-20210202","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.vaccine.2004.07.042","article-title":"Naturally-acquired immunity to Neisseria meningitidis group A.","volume":"23","author":"Amir","year":"2005","journal-title":"Vaccine"},{"key":"R20-20-20210202","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/S0264-410X(02)00221-9","article-title":"Interspecific neisserial high molecular weight proteins able to induce natural immunity responses are strongly correlated with in vitro bactericidal activity.","volume":"20","author":"Sanchez","year":"2002","journal-title":"Vaccine"},{"key":"R21-20-20210202","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1574-695X.2000.tb01419.x","article-title":"Antigenic cross-reactivity between outer membrane proteins of Neisseria meningitidis and commensal Neisseria species.","volume":"27","author":"Troncoso","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R22-20-20210202","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/JCM.22.2.152-156.1985","article-title":"Risk of group A meningococcal disease: bacterial interference and cross-reactive bacteria among mucosal flora.","volume":"22","author":"Filice","year":"1985","journal-title":"J Clin Microbiol"},{"key":"R23-20-20210202","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/IAI.6.5.651-656.1972","article-title":"Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3.","volume":"6","author":"Robbins","year":"1972","journal-title":"Infect Immun"},{"key":"R24-20-20210202","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1128\/CVI.00279-08","article-title":"Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.","volume":"15","author":"Trotter","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"R25-20-20210202","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/652765","article-title":"Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial.","volume":"50","author":"Perrett","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R26-20-20210202","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2494","article-title":"Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"R28-20-20210202","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1586\/erv.11.14","article-title":"Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.","volume":"10","author":"Blanchard-Rohner","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"R29-20-20210202","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/jama.1996.03530390048033","article-title":"Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia.","volume":"275","author":"Mulholland","year":"1996","journal-title":"JAMA"},{"key":"R30-20-20210202","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1056\/NEJMc0912599","article-title":"Influenza immunization in pregnancy-antibody responses in mothers and infants.","volume":"362","author":"Steinhoff","year":"2010","journal-title":"N Engl J Med"},{"key":"R31-20-20210202","first-page":"133","article-title":"Maternal immunity and infant responses to immunization: factors influencing infant responses.","volume":"95","author":"Siegrist","year":"1998","journal-title":"Dev Biol Stand"},{"issue":"suppl 2","key":"R32-20-20210202","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0264-410X(03)00198-1","article-title":"Antigen dependent and independent mechanisms that sustain serum antibody levels.","volume":"21","author":"Traggiai","year":"2003","journal-title":"Vaccine"},{"key":"R33-20-20210202","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2010.06.004","article-title":"Kinetics of maternal antibodies against rubella and varicella in infants.","volume":"29","author":"Leuridan","year":"2011","journal-title":"Vaccine"},{"key":"R34-20-20210202","doi-asserted-by":"crossref","first-page":"c1626","DOI":"10.1136\/bmj.c1626","article-title":"Early waning of maternal measles antibodies in era of measles elimination: longitudinal study.","volume":"340","author":"Leuridan","year":"2010","journal-title":"BMJ"},{"key":"R35-20-20210202","doi-asserted-by":"crossref","first-page":"e8088","DOI":"10.1371\/journal.pone.0008088","article-title":"The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya.","volume":"4","author":"Ochola","year":"2009","journal-title":"PLoS One"},{"key":"R37-20-20210202","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00006454-199901000-00008","article-title":"Effect of transplacentally acquired tetanus antibodies on the antibody responses to Haemophilus influenzae type b-tetanus toxoid conjugate and tetanus toxoid vaccines in Filipino infants.","volume":"18","author":"Nohynek","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"R38-20-20210202","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s004310051083","article-title":"Adverse effects and sero-responses to an acellular pertussisdiphtheriatetanus vaccine when combined with Haemophilus influenzae type b vaccine in an accelerated schedule.","volume":"158","author":"Bell","year":"1999","journal-title":"Eur J Pediatr"},{"issue":"suppl 5","key":"R39-20-20210202","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1097\/01.inf.0000160915.93979.8f","article-title":"Role of maternal pertussis antibodies in infants.","volume":"24","author":"Van Rie","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R40-20-20210202","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1128\/CVI.13.4.475-485.2006","article-title":"High titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimen.","volume":"13","author":"Nguyen","year":"2006","journal-title":"Clin Vaccine Immunol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201307000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:35:18Z","timestamp":1786048518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201307000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318292f425","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}